文献速递胸部心血管CT

肺动脉充盈缺损:鉴别体-肺动脉分流与肺栓塞

Pulmonary artery filling defects: differentiating systemic-to-pulmonary artery shunt from pulmonary embolism.
PubMed 文献 · Eur J Radiol · 2026-08-08

对26796例接受CTPA患者进行筛选,2707例存在肺动脉充盈缺损,其中273例(10.1%)经延迟期确认为体-肺动脉分流,265例(97.1%)曾被误诊为肺栓塞。研究构建SPS风险评分,用于在肺动脉充盈缺损患者中预测体-肺动脉分流。简化评分AUC为0.986,最佳界值3.5分时敏感度95.5%、特异度94.1%,验证队列敏感度100%、特异度89.7%。

要点

  • 肺动脉充盈缺损中约10%为体-肺动脉分流所致,延迟期CTA可避免误诊为肺栓塞。
  • 支气管扩张、结核后遗、肺曲菌球、咯血、单一充盈缺损、D-二聚体<2.505 mg/L提示体-肺动脉分流。
  • SPS风险评分>3.5分提示体-肺动脉分流,建议加扫延迟期CTA明确诊断。

核心结论

  • 对于存在肺动脉充盈缺损且SPS风险评分提示高风险的病例,应行延迟期CTA以准确鉴别体-肺动脉分流与肺栓塞,避免不恰当抗凝治疗。
  • 简化SPS风险评分对体-肺动脉分流具有极好的判别能力,AUC为0.986,最佳界值3.5分。

研究设计与样本

  • 回顾性筛选2020年8月至2024年8月接受CTPA检查的26796例患者,其中2707例存在肺动脉充盈缺损。
  • 依据延迟期图像将2707例肺动脉充盈缺损患者分为体-肺动脉分流组和肺栓塞组,比较影像与临床特征并评估体-肺动脉分流危险因素。
  • 建立SPS风险评分并在独立队列中进行验证。

关键影像表现/征象

  • CTPA上体-肺动脉分流可表现为假性肺动脉充盈缺损,形态上与肺栓塞相似。
  • 延迟期CTA可将体-肺动脉分流与肺栓塞进行区分,具体征象原文未进一步描述。

诊断标准与关键数值

  • 体-肺动脉分流独立危险因素:支气管扩张、结核后遗、肺曲菌球、咯血、单一肺动脉充盈缺损、D-二聚体<2.505 mg/L、无肺癌、无深静脉血栓。
  • 简化SPS风险评分最佳界值为3.5分,敏感度95.5%(253/265),特异度94.1%(2186/2324)。
  • 评分>3.5分倾向于体-肺动脉分流;独立验证队列中敏感度100%(31/31),特异度89.7%(182/203)。

临床应用与阅片要点

  • CTPA发现肺动脉充盈缺损且伴有支气管扩张、结核后遗、肺曲菌球、咯血等表现时,应警惕体-肺动脉分流。
  • 单一肺动脉充盈缺损、D-二聚体<2.505 mg/L且无肺癌或深静脉血栓者,体-肺动脉分流可能性增加。
  • 对SPS风险评分>3.5分患者应加扫延迟期CTA,避免将体-肺动脉分流误诊为肺栓塞并导致不恰当抗凝。

局限性

  • 原文未报告研究为单中心或多中心设计。
  • 回顾性研究本身存在选择偏倚的可能性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Systemic-to-pulmonary artery shunt (SPS) may present pseudo pulmonary artery filling defects (PAFDs) on computed tomography pulmonary angiography (CTPA), which can mimic pulmonary embolism (PE) and thus potentially cause misdiagnosis and inappropriate treatment.

METHODS: We screened patients who underwent CTPA between August 2020 and August 2024. Patients with PAFDs were included in the study and identified into either the PE or SPS group based on the delayed phases. The images and clinical characteristics of two groups were compared and the risk factors for SPS were evaluated. We further established an SPS Risk Scoring to predict SPS from PAFDs and validated the scoring in an independent cohort. Results Of 26,796 patients who underwent CTPA, 2,707 had PAFDs. SPS was identified in 273 patients (10.1%), of whom 265 (97.1%) were initially misdiagnosed with PE, and 44 (16.1%) received anticoagulation therapy. Independent risk factors for SPS included bronchiectasis, tuberculosis sequelae, pulmonary aspergilloma, hemoptysis, single PAFD, D-dimer < 2.505 mg/L, and the absence of lung cancer or deep vein thrombosis. The simplified SPS Risk Score showed excellent discrimination (AUC = 0.986), with an optimal cut-off of 3.5 points (sensitivity: 95.5% [253/265], specificity: 94.1% [2,186/2,324]), and scores > 3.5 favoring SPS. In the independent validation cohort, the score achieved a sensitivity of 100% [31/31], and a specificity of 89.7%[182/203]. Conclusion For patients with PAFDs and high-risk features identified by the SPS Risk Score, delayed-phase CTA should be performed to accurately differentiate SPS from PE and prevent inappropriate anticoagulation.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Guo, Jiang, Wu, et al. Pulmonary artery filling defects: differentiating systemic-to-pulmonary artery shunt from pulmonary embolism. Eur J Radiol. 2026. PMID: 42623987. doi:10.1016/j.ejrad.2026.113100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。